Essex Investment Management CO LLC Eli Lilly & CO Transaction History

Essex Investment Management CO LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 02, 2023	SELL	$321.55 - $374.67 $249,522 - $290,743	-776 Reduced 15.25%	4,314 $1.58 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $347,178 - $395,645	-1,171 Reduced 18.7%	5,090 $1.65 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $498,090 - $584,831	-1,787 Reduced 22.2%	6,261 $2.03 Million
Q1 2022 May 09, 2022	SELL	$234.69 - $291.66 $106,079 - $131,830	-452 Reduced 5.32%	8,048 $2.31 Million
Q2 2021 Aug 12, 2021	BUY	$180.55 - $233.54 $1.53 Million - $1.99 Million	8,500 New	8,500 $1.95 Million
Q3 2020 Nov 12, 2020	SELL	$146.22 - $169.13 $42,696 - $49,385	-292 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$105.9 - $118.64 $30,922 - $34,642	292 New	292 $34,000

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $749B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

Stay updated on Essex Investment Management CO LLC with notifications on news.